Provided by Tiger Trade Technology Pte. Ltd.

Madrigal Pharmaceuticals

476.91
-10.8100-2.22%
Post-market: 477.380.4700+0.10%16:15 EDT
Volume:374.37K
Turnover:178.60M
Market Cap:11.00B
PE:-33.55
High:492.33
Open:486.37
Low:466.06
Close:487.72
52wk High:615.00
52wk Low:393.61
Shares:23.06M
Float Shares:13.73M
Volume Ratio:1.41
T/O Rate:2.73%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-14.2164
EPS(LYR):-12.8501
ROE:-53.31%
ROA:-17.84%
PB:20.99
PE(LYR):-37.11

Loading ...

Alnylam Q2 Revenue Rises 67% on Increased Demand for Amvuttra

Reuters
·
Jul 30

Stock Track | Madrigal Pharmaceuticals Plunges 6.14% in Pre-market as Q2 Loss Widens and Expenses Surge Despite Revenue Growth

Stock Track
·
Jul 30

Madrigal Q2 FY26 Net Loss Widens to $57.9 Million; Net Sales Rise 71% to $364.3 Million

Reuters
·
Jul 30

Madrigal Pharmaceuticals Q2 Product Revenue USD 364.252 Million

Reuters
·
Jul 30

Madrigal Pharmaceuticals Q2 Revenue Rises 71% on Rezdiffra Demand

Reuters
·
Jul 30

Earnings Flash (MDGL) Madrigal Pharmaceuticals Posts Q2 Net Loss $1.99 a Share, vs. FactSet Est of $2.68 Loss

MT Newswires Live
·
Jul 30

Madrigal Pharmaceuticals Q2 EPS $(1.99) Beats $(2.50) Estimate, Sales $364.252M Beat $353.178M Estimate

Benzinga Earnings
·
Jul 30

Madrigal Pharmaceuticals Q2 EPS USD -1.99

THOMSON REUTERS
·
Jul 30

Madrigal Pharmaceuticals Q2 Operating Income USD -56.308 Million

THOMSON REUTERS
·
Jul 30

Madrigal Pharmaceuticals Reports Second-Quarter 2026 Financial Results and Provides Corporate Updates

THOMSON REUTERS
·
Jul 30

Madrigal Pharmaceuticals Initiated at Overweight by Wells Fargo

Dow Jones
·
Jul 27

Madrigal Pharmaceuticals initiated with an Overweight at Wells Fargo

TIPRANKS
·
Jul 27

Madrigal Pharmaceuticals price target raised to $553 from $542 at BofA

TIPRANKS
·
Jul 22

BofA Securities Adjusts Price Target on Madrigal Pharmaceuticals to $553 From $542

MT Newswires Live
·
Jul 22

Madrigal Pharmaceuticals (MDGL) Gets a Buy from UBS

TIPRANKS
·
Jul 22

Madrigal Grants Inducement Equity Awards to 10 New Hires, Sets Option Strike at $550.25

Reuters
·
Jul 22

Madrigal Pharmaceuticals Announces Grants of Inducement Awards Under NASDAQ Listing Rule 5635(c)(4)

THOMSON REUTERS
·
Jul 22

Madrigal Pharmaceuticals Announces Grants of Inducement Awards under Nasdaq Listing Rule 5635(c)(4)

GlobeNewswire
·
Jul 22

Exploring High Growth Tech Stocks In The US For July 2026

Simply Wall St.
·
Jul 20

Madrigal Pharmaceuticals Updates Financial Calendar with Quarterly Results Release, Webcast Scheduled

Reuters
·
Jul 16